These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30426245)

  • 1. Management of Locally Advanced and Metastatic Esophageal Cancer in the Older Population.
    Bracken-Clarke D; Farooq AR; Horgan AM
    Curr Oncol Rep; 2018 Nov; 20(12):99. PubMed ID: 30426245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
    Hoeppner J; Lordick F; Brunner T; Glatz T; Bronsert P; Röthling N; Schmoor C; Lorenz D; Ell C; Hopt UT; Siewert JR
    BMC Cancer; 2016 Jul; 16():503. PubMed ID: 27435280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study.
    Favi F; Bollschweiler E; Berlth F; Plum P; Hescheler DA; Alakus H; Semrau R; Celik E; Mönig SP; Drebber U; Hölscher AH
    Eur J Surg Oncol; 2017 Aug; 43(8):1572-1580. PubMed ID: 28666624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary approach to esophageal and gastric cancer.
    Stein HJ; Sendler A; Fink U; Siewert JR
    Surg Clin North Am; 2000 Apr; 80(2):659-82; discussions 683-6. PubMed ID: 10836011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
    Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
    BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
    Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
    Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distant Oncologic Outcome of Patients with Locally Advanced Unresectable and Metastatic Esophageal Cancer after Multimodality Treatment.
    Anghel R; Constantinoiu S; Bacinschi X; Gales L; Toma RV; Trifanescu O
    Chirurgia (Bucur); 2018; 113(1):116-122. PubMed ID: 29509538
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.
    Smithers BM; Thomson I
    Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal Cancer: New Insights into a Heterogenous Disease.
    Krug S; Michl P
    Digestion; 2017; 95(4):253-261. PubMed ID: 28384630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
    Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
    Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Locally Advanced Esophageal Cancer.
    Zhou N; Rajaram R; Hofstetter WL
    Surg Oncol Clin N Am; 2020 Oct; 29(4):631-646. PubMed ID: 32883463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in the treatment of esophageal cancer.
    Ilson DH
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):97-104. PubMed ID: 16163169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.
    Bolm L; Käsmann L; Paysen A; Karapetis C; Rades D; Wellner UF; Keck T; Watson DI; Hummel R; Hussey DJ
    Anticancer Res; 2018 Jun; 38(6):3231-3242. PubMed ID: 29848670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis.
    Graham AJ; Shrive FM; Ghali WA; Manns BJ; Grondin SC; Finley RJ; Clifton J
    Ann Thorac Surg; 2007 Apr; 83(4):1257-64. PubMed ID: 17383322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current evidence in support of multimodal treatment of locally advanced, potentially resectable esophageal cancer.
    Zacherl J
    Dig Dis; 2014; 32(1-2):171-5. PubMed ID: 24603404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgery after upfront radiochemotherapy for locally advanced esophageal cancer: To do or not to do?].
    Créhange G; Mabrut JY; Rouffiac M
    Cancer Radiother; 2018 Oct; 22(6-7):540-545. PubMed ID: 30174168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Esophageal carcinoma: non-surgical therapy].
    Geissler M; Schwacha H; Eggstein S; Usadel H; Harder J; Opitz O; Arnold C; Grimm CF; Blum HE
    Praxis (Bern 1994); 2004 Dec; 93(49):2057-64. PubMed ID: 15630988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Locally Advanced Thoracic Esophageal Cancer with Larynx Preservation and Curative Resection via Combined Modality Therapy].
    Iwama M; Kimura Y; Shiraishi O; Kato H; Hiraki Y; Tanaka Y; Yasuda A; Shinkai M; Imano M; Imamoto H; Yasuda T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1720-1722. PubMed ID: 29394754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern Multimodal Concepts for Advanced and Metastatic Esophageal Cancer].
    Mann C; Wille K; Tagkalos E; Grimminger P; Berlth F; Mönig SP; Fetzner UK
    Ther Umsch; 2022 Apr; 79(3-4):195-200. PubMed ID: 35440192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.